Myriad Genetics Inc Q2 Earnings Summary

WASHINGTON (dpa-AFX) – Below are the earnings highlights for Myriad Genetics Inc. (MYGN): Earnings: -$116.1 million in Q2 vs. -$14.1 million in the same period last year. EPS: -$1.42 in Q2 vs. -$0.18 in the same period last year. Excluding items, Myriad Genetics Inc. reported adjusted earnings of -$6.4 million…Read More